Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets.
| Website | http://www.absci.com |
| Employees | 158 (126 on RocketReach) |
| Founded | 2011 |
| Phone | +1 503-208-7882 |
| Technologies |
JavaScript
,
HTML
,
PHP
+91 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Generative Ai, Biologics, Drug Design, Drug Development, Biotechnology, Protein Engineering, Antibody Engineering, Accelerated Drug Development, Pharmaceutical, Machine Learning, Synthetic Biology, Therapeutics, Precision Medicine, Artificial Intelligence, Biopharmaceutical, Clinical Development |
| Competitors | Amgen, Genentech, Regeneron, Sangamo Therapeutics, Inc., Moderna Therapeutics, Invitae, Seagen, Vertex Pharmaceuticals, Editas Medicine, bluebird bio +42 more (view full list) |
Looking for a particular Absci employee's phone or email?
Sean McClain is the Founder and CEO of Absci.
126 people are employed at Absci.
Absci is based in Vancouver, Washington.